WuXi AppTec (HKG:2359, SHA:6032599) clarified media reports regarding plans to offload its ATU or advanced therapies business, saying it is still weighing its options for the continuation of the business unit, according to a Tuesday filing with the Hong Kong Stock Exchange.
The biotechnology company has not decided on the matter, and is assessing its options according to its priorities of employees and patients, the filing said.
"There is uncertainty as to whether the Company will eventually decide to dispose WuXi ATU," it said in the filing.
Shares plunged 13% in Hong Kong and gained 10% in Shanghai during Tuesday's afternoon trading.
Price (HKD): $59.80, Change: $-9.2, Percent Change: -13.33%
Comments